RT Journal Article
SR Electronic
T1 MELD Project: Atlas of lesion locations and postsurgical seizure freedom in focal cortical dysplasia
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.02.01.21250734
DO 10.1101/2021.02.01.21250734
A1 Wagstyl, Konrad
A1 Whitaker, Kirstie
A1 Raznahan, Armin
A1 Seidlitz, Jakob
A1 Vértes, Petra E
A1 Foldes, Stephen
A1 Humphreys, Zachary
A1 Hu, Wenhan
A1 Mo, Jiajie
A1 Likeman, Marcus
A1 Davies, Shirin
A1 Lenge, Matteo
A1 Cohen, Nathan T
A1 Tang, Yingying
A1 Wang, Shan
A1 Ripart, Mathilde
A1 Chari, Aswin
A1 Tisdall, Martin
A1 Bargallo, Nuria
A1 Conde-Blanco, Estefanía
A1 Pariente, Jose Carlos
A1 Pascual-Diaz, Saül
A1 Delgado-Martínez, Ignacio
A1 Pérez-Enríquez, Carmen
A1 Lagorio, Ilaria
A1 Abela, Eugenio
A1 Mullatti, Nandini
A1 O’Muircheartaigh, Jonathan
A1 Vecchiato, Katy
A1 Liu, Yawu
A1 Caligiuri, Maria
A1 Sinclair, Ben
A1 Vivash, Lucy
A1 Willard, Anna
A1 Kandasamy, Jothy
A1 McLellan, Ailsa
A1 Sokol, Drahoslav
A1 Semmelroch, Mira
A1 Kloster, Ane
A1 Opheim, Giske
A1 Yasuda, Clarissa
A1 Zhang, Kai
A1 Hamandi, Khalid
A1 Barba, Carmen
A1 Guerrini, Renzo
A1 Gaillard, William Davis
A1 You, Xiaozhen
A1 Wang, Irene
A1 González-Ortiz, Sofía
A1 Severino, Mariasavina
A1 Striano, Pasquale
A1 Tortora, Domenico
A1 Kalviainen, Reetta
A1 Gambardella, Antonio
A1 Labate, Angelo
A1 Desmond, Patricia
A1 Lui, Elaine
A1 O’Brien, Terry
A1 Shetty, Jay
A1 Jackson, Graeme
A1 Duncan, John S
A1 Winston, Gavin P
A1 Pinborg, Lars
A1 Cendes, Fernando
A1 Cross, J Helen
A1 Baldeweg, Torsten
A1 Adler, Sophie
YR 2021
UL http://medrxiv.org/content/early/2021/07/19/2021.02.01.21250734.abstract
AB Drug-resistant focal epilepsy is often caused by focal cortical dysplasias (FCDs). The distribution of these lesions across the cerebral cortex and the impact of lesion location on clinical presentation and surgical outcome are largely unknown. We created a neuroimaging cohort of patients with individually mapped FCDs to determine factors associated with lesion location and predictors of postsurgical outcome.The Multi-centre Epilepsy Lesion Detection (MELD) project collated a retrospective cohort of 580 patients with epilepsy attributed to FCD from 20 epilepsy centres worldwide. MRI-based maps of individual FCDs with accompanying demographic, clinical and surgical information were collected. We mapped the distribution of FCDs, examined for associations between clinical factors and lesion location, and developed a predictive model of postsurgical seizure freedom.FCDs were non-uniformly distributed, concentrating in the superior frontal sulcus, frontal pole and temporal pole. Epilepsy onset was typically before age 10. Earlier epilepsy onset was associated with lesions in primary sensory areas while later epilepsy onset was associated with lesions in association cortices. Lesions in temporal and occipital lobes tended to be larger than frontal lobe lesions. Seizure freedom rates varied with FCD location, from around 30% in visual, motor and premotor areas to 75% in superior temporal and frontal gyri. The predictive model of postsurgical seizure freedom had a positive predictive value of 70% and negative predictive value of 61%.FCD location is an important determinant of its size, the age of epilepsy onset and the likelihood of seizure freedom post-surgery. Our atlas of lesion locations can be used to guide the radiological search for subtle lesions in individual patients. Our atlas of regional seizure freedom rates and associated predictive model can be used to estimate individual likelihoods of postsurgical seizure freedom. Data-driven atlases and predictive models are essential for evidence-based, precision medicine and risk counselling in neurology.Competing Interest StatementThe authors have declared no competing interest.Clinical Protocols https://www.protocols.io/researchers/meld-project Funding StatementThe MELD project is supported by the Rosetrees Trust (A2665). This work is supported by the NIHR GOSH BRC. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. KSW is supported by the Wellcome Trust (215901/Z/19/Z). XY, NYC & WDG were supported by the Hess Foundation. FC and CY were supported by the Sao Paulo Research Foundation (FAPESP), Grant # 2013/07559-3 (BRAINN - Brazilian Institute of Neuroscience and Neurotechnology). JOM is supported by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (Grant Number 206675/Z/17/Z) and received support from the Medical Research Council Centre for Neurodevelopmental Disorders, King's College London (grant MR/N026063/1). PEV is a Fellow of MQ: Transforming Mental Health (MQF17_24) and of the Alan Turing Institute funded by EPSRC grant EP/N510129/1. JJM and KZ are funded by the National Natural Science Foundation of China (No. 82071457). PS acknowledges the DINOGMI Department of Excellence of MIUR 2018-2022 (legge 232 del 2016). GW is supported by the MRC (G0802012, MR/MR00841X/1). KJW is supported by The Alan Turing Institute under the EPSRC grant EP/N510129/1. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:UCL Great Ormond Street Institute of Child Health (leading the study) received approval from the NHS Health Research Authority to conduct this study on anonymised data. The study involved the sharing of anonymised patient data from each of the contributing epilepsy centres. Each individual centre received approval from their local institutional review board or ethics committee to share the anonymised data with the study coordinators.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesCode to reproduce all analyses and figures in this manuscript is available to download from github.com/MELDproject. Requests can be made for access to the full MELD dataset. https://github.com/MELDProject FCDFocal cortical dysplasiaMELDMulticentre Epilepsy Lesion Detection